Table 2:
Variables | OR | 95% CI | P-value |
---|---|---|---|
Gender | |||
Male | 0.705 | 0.318, 1.566 | 0.391 |
Female | |||
Age (years) | |||
<50 | 1.927 | 0.589, 6.289 | 0.278 |
50–70 | 2.745 | 0.976, 7.720 | 0.156 |
>70* | |||
Tumour location | |||
RUL | 0.475 | 0.056, 4.023 | 0.495 |
RML | 0.531 | 0.051, 5.553 | 0.579 |
RLL | 0.839 | 0.091, 7.769 | 0.877 |
RH* | |||
Histopathology | |||
Sq | 0.175 | 0.064, 0.480 | 0.001 |
Non-Sq | |||
Tumour size (cm) | |||
<2 | 1.829 | 0.293, 11.427 | 0.519 |
2–3 | 1.782 | 0.305, 10.413 | 0.521 |
3–5 | 2.089 | 0.349, 12.489 | 0.419 |
>5* | |||
Skipping metastasis | |||
Skipping | 0.585 | 0.271, 1.261 | 0.171 |
Non-skipping | |||
Metastasis of #2 LNs | |||
Positive | 2.598 | 1.193, 5.654 | 0.016 |
Negative | |||
Metastasis of #4 LNs | |||
Positive | 4.716 | 1.722, 12.916 | 0.003 |
Negative | |||
Metastasis of #7 LNs | |||
Positive | 0.660 | 0.274, 1.315 | 0.202 |
Negative | |||
Metastasis of #8 LNs | |||
Positive | 0.917 | 0.249, 3.376 | 0.897 |
Negative | |||
Metastasis of #9 LNs | |||
Positive | 0.481 | 0.106, 2.188 | 0.344 |
Negative |
RUL: right upper lobe; RML: right middle lobe; RLL: right lower lobe; RH: right hilum; Sq: squamous cell carcinoma; non-Sq: non-squamous cell carcinoma; OR: odds ratios; CI: confidence intervals; LN: lymph node; #: the station number of mediastinal lymph nodes;
*Reference category.